Keratomycosis, a sight-threatening fungal infection of the cornea, can be more effectively treated with a novel combination of Natamycin (NAT, 5%) and Fluconazole (FLC, 0.2%) than with NAT alone. The gene discussed is BRD2; the disease is fungal infectious disease.